Vaccines Europe conducted a pipeline review of its 15 member companies, including information up to July 2022.
The review shows a promising vaccines pipeline aimed at tackling the challenges of today and tomorrow, such as the burden of respiratory tract infections, AMR, the ageing of the population, climate change and zoonotic infections, through leveraging a broad array of technology platforms.
Download pipeline review
![]() |
Chikungunya Virus |
![]() |
Clostridioides difficile infection (CDI) |
![]() |
Coronaviruses |
![]() |
Cytomegalovirus |
![]() |
Dengue fever |
![]() |
Ebola |
![]() |
Epstein-Barr virus (EBV) infection |
![]() |
Extraintestinal pathogenic Escherichia coli (ExPEC) |
![]() |
Glioblastoma |
![]() |
Group B Streptococcus Infection |
![]() |
Hepatitis B |
![]() |
Herpes simplex virus |
![]() |
Human immunodeficiency virus (HIV) |
![]() |
Human metapneumovirus and parainfluenza virus 3 (hMPV/PIV3) |
![]() |
Influenza |
![]() |
Klebsiella pneumoniae |
![]() |
Lung/Colorectal Pancreatic cancer |
![]() |
Lyme disease (Borreliosis) |
![]() |
Malaria |
![]() |
Meningococcal disease |
![]() |
Nipah virus (NiV) |
![]() |
Pneumococcal disease |
![]() |
Rabies |
![]() |
Respiratory Syncytial Virus (RSV) |
![]() |
Shigellosis |
![]() |
Skin & soft-tissue Infections caused by Staphylococcus aureus |
![]() |
Skin cancer |
![]() |
Solid tumour |
![]() |
Varicella |
![]() |
Yellow fever |
![]() |
Zika |